Advances on anticancer new drugs in China and the USA in 2020: from ongoing trial to drug approval
{{output}}
Objectives: To describe and compare the research and development (R&D) pipeline of cancer new drugs and newly approved drugs in China and the USA in 2020, thus to provide decision-making evidence for related stakeholders. ... ...
